Related references
Note: Only part of the references are listed.SuperBiHelix method for predicting the pleiotropic ensemble of G-protein-coupled receptor conformations
Jenelle K. Bray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Use of G-Protein-Coupled and -Uncoupled CCR5 Receptors by CCR5 Inhibitor-Resistant and -Sensitive Human Immunodeficiency Virus Type 1 Variants
Reem Berro et al.
JOURNAL OF VIROLOGY (2013)
Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations
Caitlin E. Scott et al.
PROTEIN SCIENCE (2013)
Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding
Kwang H. Ahn et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2013)
Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex
Qiuxiang Tan et al.
SCIENCE (2013)
Genetically Encoded Photo-cross-linkers Map the Binding Site of an Allosteric Drug on a G Protein-Coupled Receptor
Amy Grunbeck et al.
ACS CHEMICAL BIOLOGY (2012)
An Imidazopiperidine Series of CCR5 Antagonists for the Treatment of HIV The Discovery of N-{(1S)-1-(3-Fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[321]oct-8-yl]propyl}acetamide (PF-232798)
Paul A. Stupple et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors
Reem Berro et al.
JOURNAL OF VIROLOGY (2011)
Characterizing and predicting the functional and conformational diversity of seven-transmembrane proteins
Ravinder Abrol et al.
METHODS (2011)
Predicted structures of agonist and antagonist bound complexes of adenosine A3 receptor
Soo-Kyung Kim et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Predicted 3D structures for adenosine receptors bound to ligands: Comparison to the crystal structure
William A. Goddard et al.
JOURNAL OF STRUCTURAL BIOLOGY (2010)
Elucidation of Binding Sites of Dual Antagonists in the Human Chemokine Receptors CCR2 and CCR5
Spencer E. Hall et al.
MOLECULAR PHARMACOLOGY (2009)
Flat-Bottom Strategy for Improved Accuracy in Protein Side-Chain Placements
Victor Wai Tak Kam et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
Structure of a β1-adrenergic G-protein-coupled receptor
Tony Warne et al.
NATURE (2008)
The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist
Veli-Pekka Jaakola et al.
SCIENCE (2008)
Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists
Rama Kondru et al.
MOLECULAR PHARMACOLOGY (2008)
High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor
Vadim Cherezov et al.
SCIENCE (2007)
Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation
Nagarajan Vaidehi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structural and molecular interactions of CCR5 inhibitors with CCR5
K Maeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity
P Dorr et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
The retinal conformation and its environment in rhodopsin in light of a new 2.2 Å crystal structure
T Okada et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5
K Maeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
